JOHANNESSEN JAN 4
4 · Twist Bioscience Corp · Filed Feb 18, 2022
Insider Transaction Report
Form 4
JOHANNESSEN JAN
Director
Transactions
- Exercise/Conversion
Common Stock
2022-02-16$14.00/sh+5,000$70,000→ 10,136 total - Sale
Common Stock
2022-02-16$59.20/sh−5,000$296,000→ 5,136 total - Exercise/Conversion
Director Stock Option (right to buy)
2022-02-16−5,000→ 22,304 totalExercise: $14.00Exp: 2028-10-29→ Common Stock (5,000 underlying)
Footnotes (2)
- [F1]The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on February 17, 2021.
- [F2]1/3rd of the shares subject to the option vested and became exercisable on October 30, 2019, and 1/3rd of the shares subject to the option vest and become exercisable on each annual anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.